scholarly journals FDG-PET Metabolic Vs CT Anatomical Monitoring of Tumor Response to Anterior Chemotherapy in Breast Carcinoma-The Uncertainties

2021 ◽  
Vol 19 (1) ◽  
Author(s):  
G Lohith
Keyword(s):  
Breast Carcinoma ◽  
Fdg Pet ◽  
Tumor Response

Bilateral Symmetrical Adrenal Hypermetabolism on FDG PET in Paraneoplastic Cushing Syndrome in Breast Carcinoma

2010 ◽  
Vol 35 (12) ◽  
pp. 960-961 ◽  
Author(s):  
Ankur Pruthi ◽  
Sandip Basu ◽  
Subhash K. Ramani ◽  
Supreeta Arya
Keyword(s):  
Breast Carcinoma ◽  
Fdg Pet ◽  
Cushing Syndrome

Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to Treatment

2004 ◽  
Vol 22 (5) ◽  
pp. 900-908 ◽  
Author(s):  
Hinrich A. Wieder ◽  
Björn L.D.M. Brücher ◽  
Frank Zimmermann ◽  
Karen Becker ◽  
Florian Lordick ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Esophageal Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Metabolic Activity ◽  
Fdg Pet ◽  
Time Course ◽  
Tumor Response ◽  
Patient Survival ◽  
Resected Specimen

PurposeTo evaluate the time course of therapy-induced changes in tumor glucose use during chemoradiotherapy of esophageal squamous cell carcinoma (ESCC) and to correlate the reduction of metabolic activity with histopathologic tumor response and patient survival.Patients and MethodsThirty-eight patients with histologically proven intrathoracic ESCC (cT3, cN0/+, cM0) scheduled to undergo a 4-week course of preoperative simultaneous chemoradiotherapy followed by esophagectomy were included. Patients underwent positron emission tomography with the glucose analog fluorodeoxyglucose (FDG-PET) before therapy (n = 38), after 2 weeks of initiation of therapy (n = 27), and preoperatively (3 to 4 weeks after chemoradiotherapy; n = 38). Tumor metabolic activity was quantitatively assessed by standardized uptake values (SUVs).ResultsMean tumor FDG uptake before therapy was 9.3 ± 2.8 SUV and decreased to 5.7 ± 1.9 SUV 14 days after initiation of chemoradiotherapy (−38% ± 18%; P < .0001). The preoperative scan showed an additional decrease of metabolic activity to 3.3 ± 1.1 SUV (P < .0001). In histopathologic responders (< 10% viable cells in the resected specimen), the decrease in SUV from baseline to day 14 was 44% ± 15%, whereas it was only 21% ± 14% in nonresponders (P = .0055). Metabolic changes at this time point were also correlated with patient survival (P = .011). In the preoperative scan, tumor metabolic activity had decreased by 70% ± 11% in histopathologic responders and 51% ± 21% in histopathologic nonresponders.ConclusionChanges in tumor metabolic activity after 14 days of preoperative chemoradiotherapy are significantly correlated with tumor response and patient survival. This suggests that FDG-PET might be used to identify nonresponders early during neoadjuvant chemoradiotherapy, allowing for early modifications of the treatment protocol.

Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinoma

2016 ◽  
Vol 85 (5) ◽  
pp. 943-949 ◽  
Author(s):  
Kazuhiro Kitajima ◽  
Toshiko Yamano ◽  
Kazuhito Fukushima ◽  
Yasuo Miyoshi ◽  
Seiichi Hirota ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Breast Carcinoma ◽  
Mr Imaging ◽  
Fdg Pet ◽  
Diffusion Weighted ◽  
Adc Values

Poor histologic tumor response after adjuvant therapy in basal-like HER2-positive breast carcinoma

2021 ◽  
pp. 153677
Author(s):  
Danhui Zhao ◽  
Xin Fu ◽  
Joseph Rohr ◽  
Yingmei Wang ◽  
Mingyang Li ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Adjuvant Therapy ◽  
Tumor Response ◽  
Her2 Positive

Basal 18F-FDG PET/CT as a predictive biomarker of tumor response for neoadjuvant therapy in breast cancer

2016 ◽  
Vol 35 (2) ◽  
pp. 81-87 ◽  
Author(s):  
A.M. García Vicente ◽  
A. Soriano Castrejón ◽  
R.E. Pruneda-González ◽  
G. Fernández Calvo ◽  
M.M. Muñoz Sánchez ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Neoadjuvant Therapy ◽  
Fdg Pet ◽  
Tumor Response ◽  
Predictive Biomarker ◽  
Pet Ct ◽  
18F Fdg ◽  
Fdg Pet Ct

Tumor response to neoadjuvant chemotherapy in patients with esophageal cancer assessed with CT and FDG-PET/CT – RECIST 1.1 vs. PERCIST 1.0

2018 ◽  
Vol 101 ◽  
pp. 65-71 ◽  
Author(s):  
Soichi Odawara ◽  
Kazuhiro Kitajima ◽  
Takayuki Katsuura ◽  
Yasunori Kurahashi ◽  
Hisashi Shinohara ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Fdg Pet ◽  
Tumor Response ◽  
Recist 1.1 ◽  
Pet Ct ◽  
Percist 1.0 ◽  
Fdg Pet Ct ◽  
Response To Neoadjuvant Chemotherapy

scholarly journals Occult Breast Carcinoma Presenting With Anti-Ri-Associated Paraneoplastic Cerebellar Degeneration Revealed With FDG-PET

2014 ◽  
Vol 4 (1) ◽  
Author(s):  
Aziz Bazine ◽  
Mohamed Fetohi ◽  
Maha Ait Berri ◽  
Yacir Oufroukhi ◽  
Mohamed Ichou ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Fdg Pet ◽  
Cerebellar Degeneration ◽  
Paraneoplastic Cerebellar Degeneration ◽  
Occult Breast Carcinoma

scholarly journals Radiomics based on 18 F‐FDG PET/CT could differentiate breast carcinoma from breast lymphoma using machine‐learning approach: A preliminary study

2019 ◽  
Vol 9 (2) ◽  
pp. 496-506 ◽  
Author(s):  
Xuejin Ou ◽  
Jing Zhang ◽  
Jian Wang ◽  
Fuwen Pang ◽  
Yongsheng Wang ◽  
...  
Keyword(s):  
Machine Learning ◽  
Breast Carcinoma ◽  
Fdg Pet ◽  
Learning Approach ◽  
Breast Lymphoma ◽  
Pet Ct ◽  
Machine Learning Approach ◽  
Preliminary Study ◽  
Fdg Pet Ct

The feasibility of using 18F-FDG-PET/CT in patients with mucinous breast carcinoma

2018 ◽  
Vol 39 (11) ◽  
pp. 1033-1038 ◽  
Author(s):  
Tomoyuki Fujioka ◽  
Kazunori Kubota ◽  
Yuka Kikuchi ◽  
Junichi Tsuchiya ◽  
Ukihide Tateishi ◽  
...  
Keyword(s):  
Breast Carcinoma ◽  
Fdg Pet ◽  
Pet Ct ◽  
18F Fdg ◽  
Fdg Pet Ct ◽  
Mucinous Breast Carcinoma
Sign in / Sign up

Export Citation Format

Share Document